Monopar Therapeutics Inc., a clinical-stage biopharmaceutical company, engages in developing therapeutics for the treatment of cancer in the United States. Its lead product candidate in development is Validive, a clonidine hydrochloride mucobuccal tablet that is in Phase 2b/3 clinical trial for the prevention of chemoradiotherapy induced severe oral mucositis in patients with oropharyngeal cancer. The company also engages in developing Camsirubicin, an analog of doxorubicin, which is in Phase 1b clinical trial for the treatment of advanced soft tissue sarcoma; MNPR-101, a urokinase plasminogen activator receptor targeted antibody for the treatment of various cancers; MNPR-101 RIT, a radioimmunotherapeutic based on MNPR-101 for the potential treatment of cancer and severe COVID-19; and MNPR-202, an analog of camsirubicin to potentially treat doxorubicin-and camsirubicin-resistant cancers. Monopar Therapeutics Inc. has collaborations with the Grupo Español de Investigación en Sarcomas for the development of camsirubicin in patients with advanced soft tissue sarcoma; NorthStar Medical Radioisotopes, LLC to develop radio-immuno-therapeutics targeting severe COVID-19; and the Cancer Science Institute of Singapore to evaluate the activity of MNPR-202 and related analogs in various types of cancer. The company was incorporated in 2014 and is headquartered in Wilmette, Illinois. The 2025 version of the report offers detailed insights into the company's strategies, developments, outlook and drivers. In addition to SWOT Analysis and Financial Overview, the report analyzes key projects, business description, products, services, brands, operating locations, subsidiaries and affiliates of Monopar Therapeutics Inc..
Monopar Therapeutics Inc. business operations across the value chain are included. Further, all major operating and planned locations, related contacts, details of subsidiaries and partnerships of Monopar Therapeutics Inc. are also analyzed.
Detailed SWOT Analysis of the company including key strengths and weaknesses of Monopar Therapeutics Inc. , on which it can build its business along with potential opportunities and threats in the near to medium term future are detailed.
Key employees of the company including the management team and board of directors are listed with their designations. Further, statistics on key parameters such as employee count, organization structure etc is provided.
Financial analysis of Monopar Therapeutics Inc. including key ratios, income statement, cash flow statement and balance sheet are provided for the company. In addition, Key historical events, summary analysis of Monopar Therapeutics Inc. and all latest updates of the company are provided.
The 2025 version of Monopar Therapeutics Inc. report is presented after intensive primary and secondary research processes and it presents the insights in a complete impartial and reader friendly format.
TABLE OF CONTENTS
1.1 List of Tables
1.2 List of Figures
2 Introduction to the Company
2.1 Monopar Therapeutics Inc.- Key Facts
2.2 Monopar Therapeutics Inc.- Geographic Locations
2.3 Monopar Therapeutics Inc.- Subsidiaries and Affiliates
2.4 Monopar Therapeutics Inc.- Business Divisions
2.5 Monopar Therapeutics Inc.- Key Employees
2.5.1 Management Team
2.5.2 Board of Directors
3. Monopar Therapeutics Inc. Strategic Analysis Review
3.1 Monopar Therapeutics Inc.- Key Strategies
3.2 Monopar Therapeutics Inc.- Company Outlook Statement
3.3 Monopar Therapeutics Inc.- SWOT Analysis
3.3.1 Monopar Therapeutics Inc.- Key Strengths
3.3.2 Monopar Therapeutics Inc.- Key Weaknesses
3.3.3 Monopar Therapeutics Inc.- Potential Opportunities
3.3.4 Monopar Therapeutics Inc.- Potential Threats
3.4 Monopar Therapeutics Inc.- Key Competitors
4. Business Description of the Company
4.1 Monopar Therapeutics Inc.- Business Overview
4.2 Monopar Therapeutics Inc.- Operations by Segment
5 Products and Services Details
5.1 Monopar Therapeutics Inc.- Key Products
5.2 Monopar Therapeutics Inc.- Key Service Areas
5.3 Monopar Therapeutics Inc.- Key Brands
6 Company Developments
6.1 Monopar Therapeutics Inc.- Company History
6.2 Monopar Therapeutics Inc.- Latest Developments
7 Financial Analysis
7.1 Monopar Therapeutics Inc.- Income Statements
7.2 Monopar Therapeutics Inc.- Balance Sheet
7.3 Monopar Therapeutics Inc.- Cash Flow Statements
8 Competitors and Industry Analysis
8.1 Monopar Therapeutics Inc.- Direct Competitors
8.2 Monopar Therapeutics Inc.- Competitor Financial Ratios comparison
8.3 Monopar Therapeutics Inc.- Competitor Stock Charts Comparison
8.4 Monopar Therapeutics Inc.- Industry Analysis
9 Appendix
9.1 About SWOTreports
9.2 Sources and Methodology
9.3 Contact Information
P.S.Financial Analysis will be provided only for companies reporting financial data.
Get Free Sample
At SWOT Reports, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from SWOT Reports. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
Gain valuable insights into the company for academic or business research purposes with this comprehensive profile. Key elements, such as SWOT analysis and corporate strategy, are included to support your research needs effectively.
Customer and Supplier Identification: Analyze the company’s business structure, operations, major products, services, and strategies to identify potential customers and suppliers.
Leverage a detailed SWOT analysis to understand and evaluate your competitors' business structures, strategies, and core performance metrics. This analysis offers an up-to-date and objective perspective on the company’s strengths, weaknesses, opportunities, and threats.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
Reach Out to Us
Industries
Resources
Company
Sign up for Offers & Promotions
- Connect with us
- +91 630 95 25755
- sales@swotreports.com
-
Chat on WhatsApp
